Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0677930 (
primary tumor
)
20,210
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The spread of malignant cells from a localized tumor is thought to be directly related to the number of microvessels in the tumor. The
endothelial cell-selective adhesion molecule
(
ESAM
) is a member of the immunoglobulin superfamily that mediates homophilic interactions between endothelial cells. Previous studies have indicated that
ESAM
regulates angiogenesis in the
primary tumor
growth and endothelial permeability. In this study, we aimed to further elucidate the role of
ESAM
in tumor metastasis through angiogenic processes.
ESAM
expression was higher in hypervascular metastatic tumor tissues than in normal tissues in human lungs. Cell culture studies found that conditioned medium from B16F10 melanoma cells increased
ESAM
expression in endothelial cells and promoted endothelial migration and tube formation. The B16F10 medium-induced endothelial migration and tube formation were significantly attenuated when
ESAM
was downregulated by siRNA transfection. Intravenous injection of B16F10 cells into ESAM+/+ and
ESAM
-/- mice for comparison of metastatic potential resulted in the number of metastatic lung nodules in
ESAM
-/- mice being 83% lower than of those in ESAM+/+ mice. The microvascular density in the tumor was also lower in
ESAM
-/- than in ESAM+/+ mice. These findings indicate that
ESAM
regulates tumor metastasis through endothelial cell migration and tube formation in metastatic nodules. Inhibition of
ESAM
may therefore inhibit tumor metastasis by inhibiting the angiogenic processes.
...
PMID:Role of endothelial cell-selective adhesion molecule in hematogeneous metastasis. 2015 39